Is MasterPharm LLC Safe? FDA Warning Letter Review (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on July 07, 2017
Executive Summary
The FDA issued a warning letter to MasterPharm LLC on July 07, 2017 citing regulatory violations. The letter was issued by the FDA.
Detailed Analysis
False Claims and Regulatory Violations
The FDA identified regulatory violations in MasterPharm LLC's operations or product claims.
Potential Health Risks
Stephen S. Laddy, CEOMasterPharm LLC11502 Liberty Ave, 2nd FloorSouth Richmond Hill, NY 11419-1902
Regulatory Context
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [WL #: NYK-2016-18] dated January 8, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with MasterPharm LLC?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are MasterPharm LLC products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used MasterPharm LLC products?
- If you have used products from MasterPharm LLC and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter